Chunmeng Wang

1.6k total citations
75 papers, 1.1k citations indexed

About

Chunmeng Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Chunmeng Wang has authored 75 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 28 papers in Molecular Biology. Recurrent topics in Chunmeng Wang's work include Sarcoma Diagnosis and Treatment (23 papers), Vascular Tumors and Angiosarcomas (8 papers) and Cutaneous Melanoma Detection and Management (8 papers). Chunmeng Wang is often cited by papers focused on Sarcoma Diagnosis and Treatment (23 papers), Vascular Tumors and Angiosarcomas (8 papers) and Cutaneous Melanoma Detection and Management (8 papers). Chunmeng Wang collaborates with scholars based in China, United States and Australia. Chunmeng Wang's co-authors include Yingqiang Shi, Biqiang Zheng, Wangjun Yan, Yong Chen, Peng Luo, Chunyan Du, Ye Zhou, Xi Cao, Zhengwang Sun and Wending Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Chunmeng Wang

70 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunmeng Wang China 20 526 290 283 255 100 75 1.1k
Sheng Zhou China 24 586 1.1× 190 0.7× 239 0.8× 372 1.5× 27 0.3× 46 1.1k
Piotr Potemski Poland 20 500 1.0× 143 0.5× 266 0.9× 621 2.4× 81 0.8× 119 1.4k
Ning Lü China 20 898 1.7× 94 0.3× 409 1.4× 235 0.9× 29 0.3× 48 1.3k
Hong‐Tao Xu China 26 1.2k 2.3× 336 1.2× 421 1.5× 384 1.5× 25 0.3× 125 1.9k
Run Shi China 23 685 1.3× 365 1.3× 423 1.5× 321 1.3× 23 0.2× 62 1.3k
Federica Maccarinelli Italy 19 393 0.7× 174 0.6× 124 0.4× 113 0.4× 109 1.1× 34 1.0k
Qingyun Zhang China 20 1.1k 2.0× 220 0.8× 588 2.1× 243 1.0× 23 0.2× 83 1.6k
Qichang Zheng China 19 509 1.0× 139 0.5× 255 0.9× 343 1.3× 30 0.3× 43 1.5k

Countries citing papers authored by Chunmeng Wang

Since Specialization
Citations

This map shows the geographic impact of Chunmeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunmeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunmeng Wang more than expected).

Fields of papers citing papers by Chunmeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunmeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunmeng Wang. The network helps show where Chunmeng Wang may publish in the future.

Co-authorship network of co-authors of Chunmeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chunmeng Wang. A scholar is included among the top collaborators of Chunmeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunmeng Wang. Chunmeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Ting, Biqiang Zheng, Wangjun Yan, et al.. (2025). Fruquintinib as first‐line or second‐line treatment in unresectable or metastatic soft‐tissue sarcoma: A prospective, single‐arm phase II study. Clinical and Translational Medicine. 15(4). e70308–e70308. 1 indexed citations
2.
Zhu, Chuanhe, Xianglin Ke, Yi Gu, et al.. (2025). Antimicrobial properties and preservation potential of Allium sativum L-derived extracellular vesicle-like particles for food applications. Food Chemistry. 484. 144419–144419. 1 indexed citations
3.
Sun, Yangbai, et al.. (2025). Maximal resection for malignant scalp tumors: is it valuable for long-term follow-up?. Translational Cancer Research. 14(7). 4024–4033.
4.
Cheng, Mo, Qing‐Jie Kong, Qing Tian, et al.. (2024). Osteosarcoma-targeted Cu and Ce based oxide nanoplatform for NIR II fluorescence/magnetic resonance dual-mode imaging and ros cascade amplification along with immunotherapy. Journal of Nanobiotechnology. 22(1). 151–151. 8 indexed citations
5.
Zhang, Wenxiang & Chunmeng Wang. (2024). A Novel Exposure Fusion Method Based on Low-Resolution Context Aggregation Attention Network. 1–6. 1 indexed citations
6.
Liu, Zhiqiang, Chun Liu, Zicheng Wang, et al.. (2024). Identification and validation of immune-related gene signature models for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Frontiers in Immunology. 15. 1371829–1371829. 6 indexed citations
7.
Jiang, Shiyu, Lin Kong, Yu Xu, et al.. (2023). Clinical features and prognosis of patients with metastatic ocular and orbital melanoma: A bi‐institutional study. Cancer Medicine. 12(15). 16163–16172. 5 indexed citations
8.
Liang, Yimin, Chunmeng Wang, Shiyang Yu, et al.. (2023). IOX1 epigenetically enhanced photothermal therapy of 3D-printing silicene scaffolds against osteosarcoma with favorable bone regeneration. Materials Today Bio. 23. 100887–100887. 6 indexed citations
9.
Liu, Xin, Chengcheng Gong, Jieyun Zhang, et al.. (2023). Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single-Center Study. Cancer Research and Treatment. 55(3). 1001–1010. 10 indexed citations
10.
Jiang, Shiyu, Xianghua Wu, Wangjun Yan, et al.. (2022). Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study. Clinical Cancer Research. 28(24). 5280–5289. 20 indexed citations
11.
Wang, Chunmeng, et al.. (2022). BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies. Current Treatment Options in Oncology. 23(11). 1503–1521. 37 indexed citations
12.
Buhtoiarov, Ilia N., Chunmeng Wang, Zhengwang Sun, et al.. (2022). Langerhans Cell Histiocytosis: A Population-based Study of Anatomical Distribution and Treatment Patterns. Journal of bone oncology. 36. 100454–100454. 3 indexed citations
13.
Wang, Chunmeng, et al.. (2021). Sensitivity analysis of the CROPGRO-Canola model in China: A case study for rapeseed. PLoS ONE. 16(11). e0259929–e0259929. 8 indexed citations
14.
Chen, Shuo, et al.. (2021). Predicting Prognosis in Acute Myeloid Leukemia Patients by Surface-Enhanced Raman Spectroscopy. Nanomedicine. 16(21). 1873–1885. 10 indexed citations
15.
Wu, Zhiqiang, Wei Sun, Peng Luo, et al.. (2021). CCNDBP1, a Prognostic Marker Regulated by DNA Methylation, Inhibits Aggressive Behavior in Dedifferentiated Liposarcoma via Repressing Epithelial Mesenchymal Transition. Frontiers in Oncology. 11. 687012–687012. 5 indexed citations
16.
Li, Ping, Jingwei Hu, Min Xie, et al.. (2019). Sanguinarine caused larval lethality and growth inhibition by suppressing energy metabolism in silkworms, Bombyx mori. Pesticide Biochemistry and Physiology. 160. 154–162. 20 indexed citations
17.
18.
Li, Ting, Lei Wang, Huijie Wang, et al.. (2016). A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib. Investigational New Drugs. 34(6). 701–706. 21 indexed citations
19.
Zheng, Biqiang, Linhui Liang, Chunmeng Wang, et al.. (2011). MicroRNA-148a Suppresses Tumor Cell Invasion and Metastasis by Downregulating ROCK1 in Gastric Cancer. Clinical Cancer Research. 17(24). 7574–7583. 230 indexed citations
20.
Shi, Yingqiang, Ye Zhou, Chunyan Du, et al.. (2010). The Fibroblast Growth Factor Receptor-4 Arg388 Allele is Associated with Gastric Cancer Progression. Annals of Surgical Oncology. 17(12). 3354–3361. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheng Zhou Breakdown of academic impact, for papers by Piotr Potemski Breakdown of academic impact, for papers by Ning Lü Breakdown of academic impact, for papers by Hong‐Tao Xu Breakdown of academic impact, for papers by Run Shi Breakdown of academic impact, for papers by Federica Maccarinelli Breakdown of academic impact, for papers by Qingyun Zhang Breakdown of academic impact, for papers by Qichang Zheng
Rankless by CCL
2026